HARBOURVEST PARTNERS LLC – Sigilon Therapeutics, Inc. Transaction History
HARBOURVEST PARTNERS LLC portfolio value:
$374,000
portfolio value
HARBOURVEST PARTNERS LLC quarter portfolio value change:
-39.16%
quarter
Sigilon Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -241K | $0.51 | 740.74K | |
| Q2 2022 | share | 0.00% | 0 shares | -474K | $0.83 | 740.74K | |
| Q1 2022 | share | 0.00% | 0 shares | -955K | $1.47 | 740.74K | |
| Q4 2021 | share | 0.00% | 0 shares | -2.14M | $2.86 | 740.74K | |
| Q3 2021 | share | 0.00% | 0 shares | -3.76M | $5.65 | 740.74K | |
| Q2 2021 | share | 0.00% | 0 shares | -8.60M | $10.73 | 740.74K | |
| Q1 2021 | share | 0.00% | 0 shares | -19.02M | $22.35 | 740.74K | |
| Q4 2020 | share | Increase | 0.00% | 740.74K shares | 35.57M | $48.03 | 740.74K |